Axiom Investors LLC Repligen Corp Transaction History

Axiom Investors LLC

  • $11.2 Billion
  • Q3 2024

A detailed history of Axiom Investors LLC transactions in Repligen Corp stock. As of the latest transaction made, Axiom Investors LLC holds 24,215 shares of RGEN stock, worth $3.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
24,215
Previous 40,894 40.79%
Holding current value
$3.5 Million
Previous $5.16 Million 30.11%
% of portfolio
0.03%
Previous 0.05%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$119.79 - $167.35 $2 Million - $2.79 Million
-16,679 Reduced 40.79%
24,215 $3.6 Million
Q2 2024

Aug 13, 2024
SELL
$120.0 - $182.95 $872,160 - $1.33 Million
-7,268 Reduced 15.09%
40,894 $5.16 Million
Q1 2024

May 13, 2024
BUY
$170.78 - $208.42 $8.23 Million - $10 Million
48,162 New
48,162 $8.86 Million
Q1 2023

May 12, 2023
SELL
$154.26 - $198.1 $4.86 Million - $6.24 Million
-31,520 Reduced 32.48%
65,516 $11 Million
Q4 2022

Feb 09, 2023
SELL
$162.42 - $220.56 $27.6 Million - $37.5 Million
-169,891 Reduced 63.65%
97,036 $16.4 Million
Q3 2022

Nov 10, 2022
BUY
$160.42 - $256.21 $34.8 Million - $55.6 Million
217,052 Added 435.19%
266,927 $49.9 Million
Q2 2022

Aug 11, 2022
SELL
$140.68 - $188.02 $4.01 Million - $5.36 Million
-28,533 Reduced 36.39%
49,875 $8.1 Million
Q1 2022

May 13, 2022
SELL
$161.19 - $257.96 $2.44 Million - $3.9 Million
-15,111 Reduced 16.16%
78,408 $14.7 Million
Q4 2021

Feb 11, 2022
BUY
$247.59 - $304.47 $5.26 Million - $6.46 Million
21,230 Added 29.37%
93,519 $24.8 Million
Q3 2021

Nov 12, 2021
BUY
$194.77 - $324.21 $10 Million - $16.7 Million
51,596 Added 249.34%
72,289 $20.9 Million
Q2 2021

Aug 13, 2021
SELL
$165.87 - $220.95 $1.28 Million - $1.71 Million
-7,732 Reduced 27.2%
20,693 $4.13 Million
Q1 2021

May 14, 2021
SELL
$180.37 - $226.26 $3.6 Million - $4.51 Million
-19,950 Reduced 41.24%
28,425 $5.53 Million
Q4 2020

Feb 12, 2021
SELL
$148.08 - $206.57 $3.01 Million - $4.2 Million
-20,327 Reduced 29.59%
48,375 $9.27 Million
Q3 2020

Nov 12, 2020
BUY
$122.51 - $158.27 $1.69 Million - $2.18 Million
13,775 Added 25.08%
68,702 $10.1 Million
Q2 2020

Aug 13, 2020
BUY
$94.33 - $140.48 $1.99 Million - $2.97 Million
21,127 Added 62.51%
54,927 $6.79 Million
Q1 2020

May 14, 2020
SELL
$84.96 - $109.14 $472,802 - $607,364
-5,565 Reduced 14.14%
33,800 $3.26 Million
Q4 2019

Feb 13, 2020
BUY
$73.84 - $93.08 $241,826 - $304,837
3,275 Added 9.07%
39,365 $3.64 Million
Q3 2019

Nov 13, 2019
BUY
$76.65 - $95.51 $2.77 Million - $3.45 Million
36,090 New
36,090 $2.77 Million

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Axiom Investors LLC Portfolio

Follow Axiom Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

News

Stay updated on Axiom Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email